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Abstract
Within the past few decades, lactate research has expanded from initial
findings deeming lactate as a dead-end metabolic product to recognition of
lactate’s role as a potential energy substrate in the CNS. Due to the tight
relationship between lactate and energy metabolism, interest in the scientific
community

has

dysregulation,

been

elevated

mounting
lactate

around
and

associations

neurodegenerative

among
states

metabolic
such

as

Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis, ischemia/reperfusion
(AD, PD, ALS, I/R injuries), and physiological aging, however underlying cellular
mechanisms and/or facilitators for neuronal degeneration pathologies still remain
unknown. Here, we tested several hypotheses that implicate L-lactate to various
neurodegenerative mechanisms: increases in cytosolic calcium, increases in
cytosolic reactive oxygen species (ROS), increases in intracellular acidification,
and subsequently, increases in cellular death in primary neuronal cultures and
dopaminergic-like NGF-derived PC12 cells. Treatment of cells with a pathologic
concentration of L-lactate (4 mM) induced significant increases in cytosolic
calcium, cytosolic ROS, and intracellular acidification measured in real time with
fluorescent markers and quantified using ImageJ software. Furthermore,
treatment with L-lactate (4 mM) induced significant increases in cell death,
measured in real time and using flow cytometry in support. We conclude that Llactate increases cellular events commonly observed in cells undergoing

xii

degeneration,

providing

support

for

neurodegenerative disorders.

xiii

the

implications

of

lactate

in

Literature Review
1.1 Introduction
Despite hundreds of years of study, the mechanisms behind the complex
network of physiological processes that constitute pathological human conditions
remain under investigation. At the molecular level, cells have the ability to
communicate and adapt to changes in the internal environment of the body,
which provide a dynamic means of survival and allows for continual function.
However, when cells are exposed to continuous stressors and/or fail to
effectively adapt, injury and apoptosis or necrosis ensue. Maintaining cellular
homeostasis is crucial to the proper functioning of the various bodily systems in
concert with one another. The nervous system provides the necessary machinery
for communication within the body, sensory perception of the world around us,
motor function to allow us to traverse the external environment, and autonomic
function to control organ and endocrine systems within us. The brain and spinal
cord of the central nervous system (CNS) communicate via cranial and spinal
nerves with the peripheral nervous system (PNS). Proper neuron function is
extremely important to human survival, so there are specialized adaptive
measures in the body to protect the nervous system. Neuroglial cells, such as
oligodendrocytes, microglia, and astrocytes, function to metabolically support and
provide a means of protection for neuron cells. The brain is separated from the
rest of the body by the blood brain barrier (BBB) and the cerebrospinal fluid
(CSF)-brain barrier, which create a filtered environment for neurons specialized
1

to pH, ion, and energy substrate preferences. The BBB consists of endothelial
cells connected with tight junctions, basement membrane, and astrocytes.
Oxygen, carbon dioxide, and water can freely pass through the BBB, however
larger and chemically charged molecules require regulated transport, allowing for
further protection of the CNS.
Energy homeostasis within the brain is closely regulated and a laboring
physiological task, as it accounts for nearly 20% consumption of total resting
cardiac output and oxygen (14) . The importance of homeostasis within the CNS
cannot be understated, as minutes without blood and/or oxygen supply can have
permanent damaging effects (63). Under ischemic conditions, the lack of blood
flowing to and from the brain can lead to the build-up of toxic by-products of
metabolism, increasing the rate of neuronal damage. One of the major energy
substrates used by the brain is glucose, however for this the neurons rely on
blood glucose or glycogen supplied from neuroglia. Recent studies have shown
that the brain can aerobically utilize lactate as an energy substrate via the krebs
cycle (26), and have also implicated the importance of lactate as an oxidative
energy substrate (8, 14, 56, 73).
Disruption of cellular and energy homeostasis is the hallmark of various
neurodegenerative disorders and injury to the brain. Characterized by the
deterioration of neuronal circuits, homeostasis dysregulation impairs cell-to-cell
communication critical for healthy bodily function (10). Neuronal degeneration
also occurs in the normal aging process, leading to cognition and memory
impairment. Through extensive

cellular and molecular research, common
2

mechanisms underlying neurodegenerative pathologies have been identified,
however precise etiology behind these conditions still remains largely unsolved.

1.2 Neurodegenerative Diseases
Traumatic brain injury, aging, and degenerative changes to neurons can
affect the ability to effectively process information and can damage cognitive
function. A hallmark of many neurodegenerative disorders is cognitive
impairment, which reduces the ability to perceive sensory input, process
information,

form

new

memories

and

recollect

old

ones.

Although

neuropathological diseases encompass varying symptoms or injuries, there are
similar underlying mechanisms associated with neurodegeneration such as
oxidative stress (5, 23, 47, 57, 65),

excitotoxicity (10, 15, 19, 20, 44, 62),

dysfunction of mitochondria (16, 28, 31, 32, 39, 43, 66, 68), protein aggregation
(23, 47), and alterations in gene expression (15, 47). Regardless of the
processes, it is likely to be a combination of genetic predispositions and
environmental factors that contribute to the extent and severity of these
digressions.
Aging is an inevitable process of life that encompasses similar physiological
changes that occur in pathologic neurodegeneration. A 2016 population study
demonstrated

that

autopsies

from

brains

of

aged

people

lacking

a

neurodegenerative disease diagnosis still presented with amyloid-β (Aβ),
neurofibrillary tau protein tangles, Lewy bodies, neuronal loss, and reduction in
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brain volume (22, 69). It still remains under investigation as to whether these
features are antecedents of neurodegenerative disease or artifacts of aging.
Advances in modern medicine have resulted in growth among the population of
people aged 60 and older, with numbers anticipated to increase to account for
28% of the total population in North America and 35% in Europe by 2050 (United
Nations,

2017).

With

such

a

strong

similarity

between

aging

and

neurodegeneration, precise cellular mechanisms need to be further elucidated.
In ischemic brain conditions, there is a halt in glucose delivery within minutes,
and under anaerobic conditions this can lead to increased lactate production and
exhaustion of ATP. The majority of energy use by nervous tissue is used in
maintaining ionic concentration gradients (such as the Na+/K+-ATPase pump),
which can account for fluctuations in ions such as sodium, calcium, and
potassium that are instrumental to neuronal communication and function. If the
ischemic episode is not controlled, total brain death ensues. Even if the ischemic
tissue is reperfused, this has been documented to contribute to secondary brain
injury via inflammation and noxious by-products, which can compound the
injuries received from ischemia (Figure 1-1). Of note are the role reactive oxygen
(ROS) and nitrogen species (RNS) have in ischemia reperfusion injuries,
regulating apoptosis (59, 63). Under anaerobic conditions, cellular stores of ATP
are rapidly depleted, requiring cells to produce energy via the less-effective
anaerobic respiration. This anaerobic environment impairs the ability of the citric
acid (TCA) cycle to re-oxidize NAD+ to NADH, can lead to accumulation in the
build-up of lactate, damage mitochondria and their ability to scavenge free
4

radicals, increase levels of intracellular ROS and RNS, and exacerbate cell
death. The use of antioxidants as treatment to mitigate the free radical insult is
being explored (9, 30, 50, 65).

Figure 1-1. Proposed Sequence of Events Occurring During
Ischemia/Reperfusion Injuries.
The cells that require the highest energy usage, neurons and myocytes, have
been the focus around the degenerative processes that encompass Parkinson’s
disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS),
multiple sclerosis (MS), and aging in general (23, 27, 69). A growing body of
evidence points towards the dysfunction of mitochondria as an underlying cause
of many neurodegenerative diseases such as PD (7, 27, 43), AD (5, 13, 16, 20),

5

and ALS (27, 43, 44, 60, 72). The mitochondria are key players in energy
metabolism and largely function to produce ATP. Through the glycolytic pathway,
glucose is converted to pyruvic acid in the cytosol, which then enters the
mitochondria. Once inside, pyruvate is quickly converted to acetyl coenzyme A
(coA), which enters the tricarboxylic acid (TCA) cycle. Glycolysis and the TCA
cycle only account for a net gain of 4 ATP from the original glucose molecule.
Most of the ATP used to supply cellular functions arise from the last stage of
cellular respiration: the oxygen-dependent electron transport chain, which results
in a net gain of 34 ATP. Since most of the energy generated in mitochondria
depends on the presence of oxygen to facilitate this process, cells cannot survive
efficiently for prolonged periods without fresh oxygen supply. It has been
documented that electrons can escape from the electron transport chain, and this
can be exacerbated during mitochondrial dysfunction, leading to the production
of superoxide anions, generating ROS (39). As a means of regulating ROS
formation via scavenging, mitochondria are equipped with antioxidant systems.
Only when the formation of ROS exceeds the formation of antioxidants, will the
cell undergo oxidative stress. This can occur due to abnormally high production
of ROS and/or dysfunction in free radical scavenging capabilities. ROS can
stimulate the uptake of glucose into the mitochondria, further generating more
ROS (39). Increased levels of cytosolic ROS are implicated in many pathological
states, especially AD and PD (59).

6

1.3 Glutamate Excitotoxicity
In many neurological disorders, neuronal damage can be facilitated through a
host of mediators such as excitatory neurotransmitters, free radicals, nitric oxide
(NO), inflammatory cells, and apoptotic responses. Excitotoxic injury to the brain
occurs as a result of excessive activity of excitatory neurotransmitters and their
interactions with respective receptors, and can be acute (stroke, ischemia,
trauma) or chronic (as seen in neurodegenerative disorders) in nature. The
primary excitatory neurotransmitter in the brain is glutamate, which facilitates
numerous high-order functions such as memory, cognition, motor function, and
sensory experiences. The action of glutamate occurs at glutamate family
receptor

ion

channels,

such

as

the

α-amino-3-hydroxy-5-methyl-4-

isoxazolepropionic acid receptor (AMPA-R) and the N-methyl-D-aspartate
receptor (NMDA-R). Of particular interest in studies of neurodegeneration are
ligand-gated calcium channels, which facilitate entrance of calcium into the
intracellular space, leading to increased firing and duration of action potentials
fired by neurons. Primary literature suggests calcium channel-driven implications
in CNS injury, as excessive influx of calcium into the intracellular space can
initiate a calcium-cascade of events that include acidification of the cell and the
release of enzymes that propagate cellular destruction (19, 48, 59, 71) (Figure 12).
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Figure 1-2. Calcium-Induced Apoptotic Pathway via Calcium Channel Activation.
Acute glutamate excitotoxicity can be remedied through the removal of
excess glutamate or by blocking its downstream effects. One of the cornerstones
of AD diagnosis is the presence of Aβ plaques or oligomers (38, 45, 61).
Mounting evidence points to the role of Aβ oligomers in disrupting glutamate
neurotransmission (19, 20), and Aβ has been shown to induce NMDA-R calcium
currents, oxidative stress, and apoptosis in primary cortex and hippocampal
cultures (19, 48, 51). The clinical significance of calcium channels in
neurodegeneration is supported through the Food and Drug Administration
(FDA), with their approval of Memantine, a non-competitive NMDA-R pore
blocker, as the current treatment strategy in reducing neuronal loss associated
with AD (19, 20, 25, 61).
8

1.4 Lactate
Most of the research conducted in the 1900’s was evaluating the role of lactic
acid/lactate as a by-product of energy metabolism that occurs in exercising
muscle (33, 36, 37). While this holds true, further advances in cellular and
molecular techniques are opening up avenues of further investigation of lactate
as a potentially significant energy substrate for the CNS.
Lactate (and its conjugate acid, lactic acid) has a similar chemical structure to
glutamate, which may mimick the carboxyl terminals located on each end of
glutamate (Figure 1-3). It is through this feature that lactate can partially agonize
glutamate sites at glutamatergic ion channel receptors such as NMDA-R.

Figure 1-3. Pertinent Chemical Structures.
Chemical structures of A) glutamate, B) lactic acid, and C) lactate.
One of the most significant physiologic roles of lactate is in regards to the
Cori cycle. Also known as the lactic acid cycle, it is the process by which lactate
provides an energy substrate for muscles during the anaerobic conditions of
exercise. Under normoxic conditions, the ATP needed for muscular activity is
supplied via pyruvate conversion through the TCA cycle and especially through
9

subsequent oxidative phosphorylation. Under hypoxic conditions, as occurs in
chronically working skeletal muscles, ATP supply is dependent on the less
sufficient anaerobic metabolism. Instead of entering the TCA cycle, pyruvate is
converted to lactate by the enzyme lactate dehydrogenase (LDH), which oxidizes
NADH to NAD+ in order to reduce pyruvate into lactate (Figure 1-4).

Figure 1-4. Monocarboxylate Transporter (MCT) Dysregulation.
Lactate is utilized in the mitochondria to convert to pyruvate and fuel the
tricarboxylate acid cycle (TCA). When there is cellular dysfunction, either
producing excess lactate that overwhelms the system, or through dysfunction in
MCTs, the TCA cycle does not take place, creating a feed forward mechanism
whereby lactate accumulates in the tissue.
As a means of reducing lactic acidosis experienced in muscles in an
anaerobic environment, gluconeogenesis occurs in the liver. Through this
10

process, lactate is converted back into pyruvate via LDH, with pyruvate then
converted back to glucose. This glucose travels from the liver to the muscles
through the bloodstream, where the cycle repeats itself. Gluconeogenesis is a
costly process, in terms of ATP consumed, so the Cori cycle cannot be sustained
chronically without overwhelming the cellular systems (Figure 1-5). If lactic
acidosis is sustained, this can lead to increased intracellular calcium, protein
misfolding, excitotoxicty, and subsequent cell death.

Figure 1-5. The Cori Cycle.
In exercising muscle, glucose is transported into muscle tissue by glucose
transporter (GLUT), where glycolysis then takes place, converting one glucose
molecule into two pyruvate molecules and generating a net gain of 2 ATP.
Lactate dehydrogenase (LDH) converts the two molecules of pyruvate into two
molecules of lactate, oxidizing NADH to utilize the electrons. Lactate is
transported out of muscle, into the bloodstream, and into liver cells through the
monocarboxylate transporter (MCT). In the liver, gluconeogenesis takes place,
converting lactate back into glucose, at the expense of 6 ATP.
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Lactate transfer across cell membranes is facilitated by transmembrane
proteins called monocarboxylate transporters (MCTs). As their name suggests,
these co-transporters allow for bi-directional movement of monocarboxylates
(such as lactate and pyruvate) and protons across cellular membranes in a
concentration and pH-dependent manner (34). These transporters allow for the
flow of lactate from astrocytes to neurons to be used as an energy substrate in
anaerobic conditions (8, 49, 53, 64, 70), and also intracellular expression for
movement of lactate in and out of mitochondria (29, 34, 60). Dysregulation of
MCT’s are implicated in rises in lactate concentrations and subsequent acidosis
and if prolonged, cell death (53).
Recent literature is pointing towards the significance of lactate as an energy
substrate. The biochemical make-up of blood, extracellular fluid, and CSF are
varying, with specific regulatory measures for maintaining proper homeostasis.
These different fluids have varying content of energy substrates: it has been
reported via microdialysis data collected from humans and rats that baseline
glucose and lactate concentration in the extracellular fluid of the cortex and
hippocampus is about 1-2 mM and 2-5 mM (respectively), with blood glucose and
lactate concentrations reaching about 5-7 mM and 1-2 mM (respectively) (1).
Another study with a rat model showed that in vivo, a shift in energy substrate
concentrations occurred in extracellular fluid upon electrical stimulation.
Increased neuronal activity induced a decrease in glucose concentration and a

12

significant increase in lactate concentrations (36). Taken together, these findings
point towards the potential of lactate as a preferred energy source for neurons.
Interestingly, in majority of persons diagnosed with ALS, a neurodegenerative
disease characterized by gradual loss of motor neurons and subsequent
muscular atrophy, the muscular function of the eyes remain working. It has been
shown that ocular muscles and nerves use lactate as an energy substrate, thus
these tissues do not fatigue when exposed to lactic acid as is seen in skeletal
musculature (4). Furthermore, it has been reported that LDH activity is detected
in eye muscles (37) and oculomotor neurons (33). Taken together, these findings
suggest that the eye muscles and associated neurons possess the cellular
machinery to withstand abnormally high amounts of lactate without subsequent
cellular degeneration. The existence of an ATP-dependent muscular-neuronal
lactate shuttle (MNLS) has been proposed as a means of sustaining lactate
homeostasis among motor neurons and muscles (44). Dysfunction among LDH,
mitochondria and/or the MNLS are all proposed mechanisms by which lactate
can accumulate at the neuromuscular junction (NMJ) and contribute to the
toxicity factor in the pathogenesis of ALS.

1.5 Cerebrospinal Fluid Abnormalities
Cerebrospinal fluid (CSF) lactate concentrations are used as an analytical
tool in diagnosing nervous system infections, such as bacterial and aseptic
meningitis (54). Alteration in lactate CSF levels has been gaining momentum in
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the research world as an indicator of many neurodegenerative diseases. A 2016
study reported elevated concentrations of CSF lactate in relapsing-remitting
multiple sclerosis (MS) patients (n=118) that increased with increased disease
progression, indicated by factors such as progression index (PI), MS severity
scale (MSSS), and Beyesian risk estimate for MS (BREMS) (2). Also indicated in
this study was a positive and significant correlation between CSF lactate and
CSF concentrations of tau and neurofilament proteins, well-accepted markers for
neurodegenerative disorders. A recent study of patients who were diagnosed
with a variety of neurodegenerative diseases such as ALS, PD, and Huntington’s
disease, demonstrated an increase in CSF lactate levels of neurodegenerative
patients aged 65 years and older compared to their younger counterparts, and a
positive correlation between CSF lactate and glucose levels.
An elevation of lactate in the CSF (typically considered > 2.1 mM) can be a
crucial

indicator

of

mitochondrial

dysfunction,

which

is

implicated

in

neurodegenerative disease progressions as mentioned. It has been shown
however, that patients with mitochondrial disease may have normal CSF lactate
concentrations except when enduring cellular stress, as experienced in
metabolically demanding tasks such as strenuous exercise (32). If a disease
presents with mitochondrial dysfunction, this would facilitate an environment of
increased metabolic stress, thus increasing the levels of lactate that accumulate
in the CSF.

14

1.6 Hypothesis
Major findings in cellular mechanistic neurodegenerative studies include:
increased ROS, glutamate excitotoxicity, increased cytosolic calcium, and cell
and body acid/base issues (Figure 1-6).

Figure 1-6. Lactate Accumulation Contribution to Cytotoxicity.
We hypothesized that since a majority of neurodegenerative diseases
present with elevated lactate concentrations, the lactate may serve as an
exictatory feed forward mechanism propagating not only cell death, but also
contributing to β-amyloid and cognitive decline. Therefore, in this study we
explored the effects of lactate on apoptosis, cytsolic reactive oxygen species,
intracellular calcium concentrations, and cytosolic pH in dopaminergic-like PC12
cells.

15

Elevated L-lactate Drives Major Cellular Pathologies
Associated with Neurodegeneration
2.1 Abstract
Within the past few decades, lactate research has expanded from initial findings
deeming lactate as a dead-end metabolic product to recognition of lactate’s role
as a potential energy substrate in the CNS. Due to the tight relationship between
lactate and energy metabolism, interest in the scientific community has been
mounting around associations among metabolic dysregulation, elevated lactate
and neurodegenerative states such as AD, PD, ALS, I/R injuries, and
physiological aging, however underlying cellular mechanisms and/or facilitators
for neuronal degeneration pathologies still remain unknown. Here, we tested
several hypotheses that implicate L-lactate to various neurodegenerative
mechanisms: increases in cytosolic calcium, increases in cytosolic reactive
oxygen species (ROS), increases in intracellular acidification, and subsequently,
increases in cellular death in primary neuronal cultures and dopaminergic-like
NGF-derived PC12 cells. Treatment of cells with a pathologic concentration of Llactate (4 mM) induced significant increases in cytosolic calcium, cytosolic ROS,
and intracellular acidification measured in real time with fluorescent markers and
quantified using ImageJ software. Furthermore, treatment with L-lactate (4 mM)
induced significant increases in cell death, measured in real time and using flow
cytometry in support. We conclude that L-lactate increases cellular events
commonly observed in cells undergoing degeneration, providing support for the
implications of lactate in neurodegenerative disorders.
16

2.2 Introduction
Cell homeostasis is critical to healthy bodily functions, and fluctuations in
the cell environment lead to the activation of various compensatory mechanisms
to ensure appropriate function. Proper homeostatic function is especially critical
in the central nervous system (CNS), as pathological changes in intracellular and
extracellular environment of neurons are observed in patient’s experiencing
neurodegeneration, both in disease models and as a result of normal aging (11,
15, 49, 69).
. A key player in energy homeostasis within cell bodies, including neurons,
are the mitochondria. Active mitochondria generate ATP and NAD+ for cells, and
in neurons this provides energy to keep pre- and post-synaptic sites functioning
properly (70, 73). The early symptoms of dementia such as confusion and
memory loss have been linked to synaptic dysfunction due to build up of βamyloid oligomers characteristic of AD (20) and increased oxidative stress in
mitochondria (47, 65, 66). Age has also been identified as one of the greatest
risk factors for development of dementia (69), however additional factors such as
glutamate excitotoxicity (8, 44, 45, 62), intracellular calcium-induced cascades
(30, 63), oxidative stress (23, 57), and inflammatory factors (35, 47) can also
increase the risk of developing neuronal loss characterized in degenerative
diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD),
amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and normal human
aging. Mitochondrial dysfunction can lead to reduced energy/ATP generation
17

(11), impaired free radical scavenging capabilities (52) and dysfunctional
monocarboxylate transporters (29, 34, 70). It is through these impaired cellular
processes that ROS accumulates in cell bodies such as neurons, eventually
triggering an apoptotic-cascade ending in neuronal death. The Alzheimer’s
Association estimates that 5.5 million Americans live with AD (2017), with
majority of AD patients at least 65 years of age or older. Due to advances in
medicine and subsequent prolonged life expectancy, the prevalence of
neurodegenerative disorders is predicted to dramatically increase, pressing a
huge demand on the scientific and medical community for better understanding
of neurodegeneration to employ more effective treatments.
For most of the 19th and 20th centuries, lactate was only regarded as a
dead-end product in exercising muscles after metabolism, but current research is
reconsidering the role and significance of lactate as: (1) a fuel source to meet the
energetic requirements of neurons (4, 8, 14, 26, 29, 44, 53, 56, 64, 70, 73) and
(2) a necessary signaling molecule for neuronal plasticity (71). Furthermore,
research has been conducted in primary culture mouse neurons and in vivo
showing that L-lactate can function as a signaling molecule that stimulates
plasiticity-related gene expression in neurons (71), in addition to functioning as
an energy substrate for neurons. On a molecular basis, L-lactate functions as a
mediator for long-term plasticity and memory through the induction of expression
of immediate early genes (IEGs), such as early growth response 1 (Egr1), c-Fos,
and Arc. This is achieved via action at N-methyl-D-aspartate receptors (NMDA-
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R), as MK801, an NMDA-R antagonist, completely abolished L-lactate-induced
Arc and Egr1 expression (71).
There is a growing basis of research indicating that accumulation of
lactate in the central nervous system, through impairment of MCTs (29, 34, 70),
altered activity of lactate dehydrogenase (LDH), and/or hypoxic/ischemic
conditions (63), can lead to metabolic acidosis, increased ROS, and increased
levels of intracellular calcium. In anaerobic conditions, as occurs in hypoxia or
ischemia, mitochondrial oxidative phosphorylation is impaired, leading to an
increased production of lactate and if prolonged, deleterious cellular responses
such as cytosolic acidosis (42). Protein structure and function is largely regulated
by chaperone molecules, such as GRP78 and CHOP, and lactic acidosis can
contribute to conformational changes to these molecules, reducing their activity
and further exacerbating the acidosis. Blood lactate concentrations are usually 12 mM at rest, however with excess accumulation as experienced during intense
exercise, these levels can exceed 20 mM (12). Blood or CSF lactate increases
(>2.1 mM) (32) can be an indicator of mitochondrial disease, however this
dysfunction can go undetected in patients due to normal pyruvate and lactate
levels except when the individual is exercising or has been subjected to adverse
metabolic conditions (such as seen in ischemic injuries and neurodegenerative
states). Rises in CSF lactate have been well established in neurodegenerative
disease models (2, 3, 44, 49, 62, 71, 72).
In this study we attempt to eluicidate more precise cellular mechanisms
associated

with

the

cognitive

and
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memory

decline

surrounding

neurodegeneration. As the CNS functions primarily though the use of
neurotransmitters, such as the excitatory transmitter glutamate, disregulation or
aberrant expression of neurotransmitters has been well established in CNS
pathologies. The excitotoxic result of excessive glutamate binding occurs through
increased calcium influx into the cell, triggering a cascade of neurotoxic cellular
events, such as neuronal depolarization and binding with calmodulin to lead to
increased

nitric

oxide

(NO)

formation.

This

can

further

exacerbate

neurodegeneration. Based on mounting evidence, we posit that lactate is a key
player in many of the pathological states that occur during the development and
progression of neurodegeneration. Elevated levels of cerebral spinal fluid (CSF)
lactate, chronically, can lead to cytotoxic insult and ensuing cell death (as
observed in strokes, ischemia reperfusion injuries, and neurodegeneration).
Therefore, we hypothesized that administration of lactate to primary neuronal
cultures and dopaminergic-like NGF-derived PC12 cells would elicit increases in
cell death, intracellular calcium, intracellular reactive oxygen species (ROS), and
cytosolic acidification; all hallmark aspects of neurodegeration processes (Figure
2-1).
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Figure 2-1. Hypothesis Model for Lactate-induced Cell Death.
Lactate binds with calcium channel receptors that induce an influx of calcium into
the cell body. Intracellular calcium elicits increases in neuronal excitability and
decreases in cytosolic pH that can directly contribute to cell death. Cytosolic
calcium also increases reactive oxygen species (ROS) formation, creating a
positive-feedback loop, inducing oxidative stress in the mitochondria, leading to
increased production of lactate, decreases in pH, and further increases
intracellular calcium. Oxidative stress is often followed by ER stress in
dysfunctional cellular environments, further increasing cytosolic ROS. If ER
stress is prolonged, protein aggregates begin accumulating, eliciting the unfolded
protein response (UPR). Activation of the UPR leads to increased mRNA
expression of GRP78, and the accumulation of protein aggregates can contribute
to G2 cell cycle arrest. DNA damage due to oxidative stress is another
contributor to G2 cell arrest. Taken together, these mechanisms can further
exacerbate cell death.

2.3 Methods
2.3.1 NGF-Derived PC12 Cell Culture
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PC12 cells (American Type Culture Collection, USA) were prepared by
placing cells in a 37.9 °C media cocktail containing: 50 mL of Dulbecco’s
Modified Eagle Medium (DMEM), 10% horse serum (HS), 5% fetal bovine serum
(FBS), 1% penicillin, and nerve growth factor (NGF) at 20 ng/mL. Cells were
plated according to the experiment to be run (24 well plates; ThermoFisher) and
placed in a 37.5 °C humidified CO2 (5%) incubator. Cells were grown to 75-80%
confluency and not passaged more than 10 times before new cells were used.
2.3.2 Preparation of Neuronal Cultures
Whole brain neuronal cultures were made from 1 day old SD rats
according to our previous publication (58). Briefly, rats were anesthetized with
pentobarbital (50 mg/kg) and the brains extracted, dissected, combined, brain
cells dissociated and cells plated on poly-L-lysine pre-coated culture dishes. Two
days following plating, cultures were treated for two days with cytosine
arabanoside (ARC, 10μM) to kill off rapidly dividing cells (astroglial and
astrocytes) followed by fresh ARC free media for the remainder of cultures.
Neuronal cultures contained > 90% neurons with the remainder primarily
astroglial. Neuronal cell cultures were grown for 10-14 days before use in cell
culture experiments.
2.3.3 Cell Treatment
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Before application of treatments, cells were observed for healthy neurite
outgrowth. Once cells were deemed viable, the previous cell media was
aspirated and cells were rinsed with 12 mL artificial cerebral spinal fluid (aCSF)
to wash away any residual media (0.5 mL/well). The lactate treatment stock
solution was was diluted with DMEM to the correct concentration. The lactate
treatment was heated to 37.9 °C, added to the 24 well plate (0.5 mL/well), and
then placed back into the 37.5 °C humidified CO2 (5%) incubator for 4 h. This
treatment protocol was followed for all treatments in this research, with treatment
times specified (1 h or 4 h).
2.3.4 Flow Cytometry
Prior to flow cytometry preparations, PC12 cells were observed for healthy
neurite outgrowth/cell viability. The previous treatment media was aspirated from
the wells and cells were rinsed with 12 mL artificial cerebral spinal fluid (aCSF) to
wash away residual media (0.5 mL/well). Cells were then treated with 12 mL (0.5
mL/well) trypsin EDTA warmed to 37.9 °C, and gently shaken for several minutes
until cells were loosened from the bottom of the wells. To neutralize the trypsin,
12 mL (0.5 mL/well) of DMEM (with 10% HS and 1% antibiotics) was added to
the wells and gently swirled to ensure proper mixing of the trypsin and DMEM.
This mixture from each well was transferred to individual 1.5 mL centrifuge tubes
(ThermoFisher) and centrifuged for 2 m at 1000 rotations per minute (RPM’s).
The supernatant was aspirated from each tube and cells were re-suspended in
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12 mL (0.5 mL/well) of live cell imaging solution (LCIS, ThermoFisher). One drop
of propidium iodide (PI) ReadyProbes (ThermoFisher) was added to each tube of
cells/LCIS, and the tubes were then vortexed to break up the cell pellet at the
bottom of the tube. The tubes were covered with aluminum foil to protect against
light damage and were incubated at room temperature for 20 m before starting
data collection on the flow cytometer (BD Accuri C6; BD Bioscience). Flow
cytometry was conducted in triplicates for each experiment with 10,000 cells per
run. The PI staining was measured in percentages based off control groups and
analysis parameters were kept consistent among treatment and control groups.
To measure cytosolic reactive oxygen species (ROS), CellROX Orange
(ThermoFisher) probe was used instead of PI. The same cell preparation
procedures were used as above, with the CellROX Orange prepped with LCIS in
accordance with the protocol provided by ThermoFisher. The LCIS/CellROX
cocktail was added into each 1.5 mL centrifuge tube (0.5 mL/tube), tubes were
covered with aluminum foil to protect against light damage, and cells were
allowed to incubate at room temperature for 30 m. After 30 m, the tubes were
centrifuged at 1000 RPM’s for 2m. Supernatant was aspirated, 12 mL fresh LCIS
(37.9 °C) was added to the centrifuge tubes (0.5 mL/tube), and the tubes were
vortexed before data collection was carried out on the flow cytometer.
2.3.5 Real-Time Imaging
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Following 4 h treatment with DMEM (control) or L-lactate (4 mM) in
DMEM, NGF-derived PC12 cells were prepared for real-time imaging with probes
to measure for: calcium (Fluo-4AM, ThermoFisher), apoptosis (propidium iodide,
ReadyProbe, ThermoFisher), ROS (CellROX Orange, ThermoFisher), and pH
(pHrodo red AM, ThermoFisher).
For the calcium imaging, previous treatment media was aspirated from
each well, rinsed with aCSF (0.5 mL/well), and aspirated again. Fluo-4AM dye
was added to aCSF to a final concentration of 3 μM and was applied to the cells
(0.5 mL/well). Cells were incubated at 37.9 °C for 30 m and then the media was
aspirated from the wells. LCIS was added (1 mL/well) and viewed under an
inverted microscope (Leica) with the appropriate fluorescent filters, a digital
camera, mercury burner, and connection to a computer equipped with image
capture software (Leica). After images were captured for each well, the
backgrounds of the images were normalized and fluorescence was quantified
using ImageJ software prior to background normalization. The analysis was
completed using 6 randomly selected cells per treatment group and differences
in intensity were compared among groups.
For the apoptosis imaging, treatment media was aspirated and each well
was rinsed with aCSF (0.5 mL/well) to remove residual media. The aCSF was
aspirated, cells were re-suspended in LCIS (0.5 mL/well), and 1 drop of PI
ReadyProbe dye and 1 drop of NucBlue ReadyProbe (ThermoFisher) dye was
added to each well according to the manufacture’s instructions . The cells were
covered in foil and incubated at room temperature for 30 m before imaging.
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The oxidative stress detection probe, CellROX Orange, was prepared
according to ThermoFisher’s protocol to final concentration of 5 μM. Previous
treatment media was aspirated from each well, cells were re-suspended in the
CellROX reagent, and incubated at 37.9 °C for 30 m. This media was removed
and 0.5 mL of fresh LCIS with 1 drop of NucBlue was added to each well,
incubated at room temperature (protected from light) for 20 m before imaging.
To measure intracellular pH, pHrodo red-AM was prepared in LCIS
according to manufacturer’s protocol. Previous treatment media was aspirated
and each well was rinsed once with LCIS (0.5 mL/well). The LCIS was aspirated,
cells were re-suspended in the prepared pHrodo red-AM staining solution (0.5
mL/well), and incubated at room temperature (protected from light) for 30 m. The
staining solution was removed and cells were re-suspended in fresh LCIS (0.5
mL/well) before imaging.
2.3.6 Neuronal mRNA Expression Levels
Whole brain primary neuronal cell cultures were treated with DMEM (control)
or L-lactate (4mM) in DMEM for 1 h or 4 h prior to extraction. An RNA extraction
kit (Qiagen) was used in accordance with the manufacturer’s instructions to
extract the mRNA. The mRNA was converted to cDNA by the use of SuperScript
VILO (ThermoFisher), with concentrations normalized to 250 ng/μL. Real time
PCR (StepOnePLus real-time PCR system, Applied Biosystems) was conducted
to measure mRNA levels of GAPDH (control), c-Fos, EGR1, GRP78, CHOP, and
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VMAT2 using the respective primers (Applied Biosystems). Experiments were
performed in quadruplicates and data was analyzed via Data Assist V. 3.01
(Applied Biosystems) for changes in mRNA expression levels using GAPDH as
the selected control.
2.3.7 Statistical Analysis
Data values were reported as mean ± SE. Group means were compared
using either unpaired Student’s t-test, or a one-way ANOVA (depending upon the
experiment). Significant difference between means was considered at p < 0.05.
Bonferroni post hoc tests were used for multiple pair-wise comparisons among
differences. Statistical analyses were performed using GraphPad Prism, version
5.0.
2.3.8 Chemicals
All chemicals/cell culture reagents and supplies were obtained from
ThermoFisher, USA, with the exception of nerve growth factor (NGF, Sigma
Aldrich) and L-lactate (Sigma Aldrich).

2.4 Results
2.4.1 L-lactate Increases Cytosolic Calcium in Primary Neuronal Cultures
Primary neuronal cultures were incubated with DMEM (control) (Figure 22A) or L-lactate (4 mM) in DMEM (Figure 2-2B) for 4 h, co-stained with Fluo-4AM
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(ThermoFisher), a Ca2+ binding fluorescent dye, and NucBlue, and imaged in
real-time under an inverted microscope.
Fluorescence intensity was quantified using ImageJ software. Treatment
of cells with L-lactate (4 mM) significantly (p < 0.05) increased the amount of
cytosolic calcium in both neurons and PC12 cells (Figure 2-2C), compared to
control.

Figure 2-2. L-lactate Increases Cytosolic Calcium in Neurons.
(A) Control cells were treated with DMEM for 4 h before being co-stained with
Fluo-4AM and NucBlue. Real-time images were taken at 40x and 200x
magnification. (B) Cells were treated for 4 h with L-lactate (4 mM) before being
prepped for imaging. Real-time images were taken at 40x and 200x
magnification. (C) The fluorescence intensity of the neurons treated with L-lactate
(4 mM) or DMEM (control) and stained with Fluo-4AM, a cytosolic calcium stain,
was quantified. The lactate treatment significantly (p < 0.05) increased the
amount of cytosolic calcium compared to control.
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2.4.2 L-lactate Increases Cytosolic ROS in Primary Neuronal Cultures and
Dopaminergic-Like PC12 Cells
Primary neuronal cell cultures were treated with either control DMEM
(Figure 2-3A) or 4 mM L-lactate (Figure 2-3B), co-stained with cellROX orange
and NucBlue (ThermoFisher), and analyzed in real time under an inverted
microscope with appropriate fluorescent burner. Fluorescence intensity was
quantified using ImageJ software. Treatment of cells with 4 mM L-lactate (n = 6)
significantly increased the amount of cytosolic reactive oxygen species (ROS)
compared to control (n = 6) (Figure 2-3C).
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Figure 2-3. L-lactate Increases Cytosolic ROS in Neurons.
(A) Control cells were treated with DMEM for 4 h before being co-stained with
CellROX orange and NucBlue. Real-time images were taken at 40x and 200x
magnification. (B) Cells were treated for 4 h with L-lactate (4 mM) before being
prepped for imaging. Real-time images were taken at 40x and 200x
magnification. (C) The fluorescence intensity of the neurons treated with L-lactate
(4 mM) or DMEM (control) and stained with CellROX orange, a cytosolic ROS
stain, was quantified. The lactate treatment significantly (p < 0.05) increased the
amount of cytosolic ROS compared to control.
NGF-derived PC12 cell cultures were treated with either control DMEM
(Figure 2-4A) or 4 mM L-lactate (Figure 2-4B), co-stained with cellROX orange
and NucBlue (ThermoFisher), and analyzed in real time under an inverted
microscope with appropriate fluorescent burner. Fluorescence intensity was
quantified using ImageJ software. Treatment of cells with 4 mM L-lactate (n = 6)
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significantly increased the amount of cytosolic reactive oxygen species (ROS)
compared to control (n = 6) (Figure 2-4C).

Figure 2-4. L-lactate Increases Cytosolic ROS in PC12 Cells.
(A) Control cells were treated with DMEM for 4 h before being co-stained with
CellROX orange and NucBlue. Real-time images were taken at 200x
magnification. (B) Cells were treated for 4 h with L-lactate (4 mM) before being
prepped for imaging. Real-time images were taken at 200x magnification. (C)
The fluorescence intensity of the PC12 cells treated with L-lactate (4 mM) or
DMEM (control) and stained with CellROX orange, a cytosolic ROS stain, was
quantified. The lactate treatment significantly (p < 0.05) increased the amount of
cytosolic ROS compared to control.
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2.4.3 L-lactate Increases Intracellular Acidification in Primary Neuronal
Cultures and Dopaminergic-Like PC12 Cells
Primary neuronal cultures (Figure 2-5A) and NGF derived PC12 cells
(Figure 2-5C) were treated with either control DMEM or L-lactate (4 mM) for 4 hrs
and then stained with pHrodo-red (ThermoFisher), a pH indicator that increases
in fluorescence as pH becomes more acidic, and analyzed in real time. Images
were captured for both treatment groups at 200x magnification and for PC12
cells at 40x magnification.
Fluorescence intensity was quantified using ImageJ software. Treatment
of cells with 4 mM L-lactate significantly (p < 0.01) increased the amount of
intracellular acidification compared to control, in both neuronal cultures (Figure 25B) and PC12 cells (Figure 2-5D).
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Figure 2-5. Real Time pH Imaging.
(A) Neurons were treated with DMEM as a control or L-lactate (4 mM) and
stained with pHrodo red. Images were taken at 40x. (B) L-lactate significantly (p
< 0.01) increased the amount of cytosolic acidification in neuronal culture treated
for 4 h. (C) PC12 cells were treated with DMEM or L-lactate (4 mM) for 4 h
before being stained with pHrodo red. Images were taken at 40x and 200x
magnification. (D) L-lactate significantly (p < 0.01) increased the amount of
cytosolic acidification in PC12 cells treated for 4 h.
2.4.4 L-lactate Alters Expression of Synaptic Plasticity Genes c-Fos and
EGR1 in Primary Neuronal Cultures
Primary neuronal cultures incubated with L-lactate (4 mM) had
significantly (p < 0.0001) increased mRNA expression levels of the immediate
early gene (IEG), c-Fos (Figure 2-6A), at 1 h versus control (5.77 ± 0.38 vs 1.01
± 0.06 fold). The mRNA expression level of c-Fos at 4 h decreased significantly
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(p < 0.0001) versus 1 h (0.10 ± 0.03 vs 5.77 ± 0.38) and control (0.10 ± 0.03 vs
1.01 ± 0.06 fold).
Neurons treated with L-lactate (4 mM) induced a significant (p < 0.05)
increase in mRNA expression of the immediate early gene (IEG) and
transcription factor, early growth response 1 (EGR1) at 1 h compared to control
(2.16 ± 0.17 vs 1.01 ± 0.06 fold). No difference was found at 4 h, as levels
returned towards baseline. (Figure 2-6B).
2.4.5 L-lactate Induces Unfolded Protein Response in Primary Neuronal
Cultures
Primary neuronal cultures treated with L-lactate (4 mM) elicited a
significant (p < 0.0001) decrease in the mRNA expression levels of CHOP (also
known as DDIT3), a protein activated during ER stress, at 4 h versus control
(0.06 ± 0.00 vs 1.01 ± 0.06), with no change in mRNA levels found at 1 h (Figure
2-6C).
A significant (p < 0.05) increase in mRNA expression levels of GRP78
(also called HSPA5 or BiP) an ER chaperone, was induced in neurons at 4 h
following L-lactate (4 mM) treatment versus control (1.40 ± 0.09 vs 1.01 ± 0.06,
although no significance was found at 1 h (Figure 2-6D).
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2.4.6 L-lactate Increases VMAT2 mRNA Expression in Primary Neuronal
Cultures
Primary neuronal cultures treated with L-lactate (4 mM) elicited a
significant (p < 0.0001) increase in the mRNA expression levels of VMAT2, a
protein involved in maintenance of neuronal vesicles, at 1 h versus control (0.06
± 0.00 vs 1.01 ± 0.06), with no change in mRNA levels found at 4 h (Figure 26E).

Figure 2-6. Effect of L-lactate on mRNA Expression Levels in Primary Neuronal
Cultures.
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(A) L-lactate (4 mM) significantly (p < 0.0001) increased the mRNA expression
level of c-Fos at 1 h compared to control, and significantly decreased the mRNA
levels of c-Fos at 4 h compared to 1 h (*** vs control, ### vs 1 h). (B) L-lactate (4
mM) significantly (p < 0.0001) increased the mRNA expression level of EGR1 at
1 h compared to control, although no difference was observed at 4 h (*** vs
control). (C) L-lactate (4 mM) significantly (p < 0.0001) decreased the mRNA
expression level of CHOP at 4 h compared to control (### vs control). No
difference was observed at 1 h. (D) L-lactate significantly (p < 0.01) increased the
mRNA expression level of GRP78 at 4 h compared to control (* vs control). (E) LLactate significantly (p < 0.0001) increased mRNA expression level of VMAT2 at
1 h compared to control (*** vs control).
2.4.7 L-lactate Increases Cell Death in Primary Neuronal Cultures and
NGF-Derived PC12 Cells
Neuronal cultures were treated with either control DMEM or 4 mM Llactate in DMEM, loaded with PI and NucBlue ready probes (ThermoFisher), and
analyzed in real time. The 4 mM L-lactate treatment stimulated an increase in
cells staining positive for PI compared to control (Figure 1E). There was no
significant (p < 0.05) difference between the amount of neurons staining positive
for NucBlu between control and the treatment group. Images were captured for
controls at 40x magnification and 200x magnification (Figure 1A) and 4 mM Llactate at 40 and 200x magnification (Figure 1B).
Neuronal cultures treated with either control DMEM (n=5) or 4 mM Llactate (n=6) were stained with PI and analyzed via flow cytometry. The amount
of cells staining positive for PI increased in the 4 mM L-lactate treatment group
(31.6%) compared to the control group (21.4%) (Figure 1D).
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Figure 2-7. L-lactate Increases Cell Death in Primary Neuronal Cultures.
(A) Cells were treated with DMEM as a control, co-stained with PI and NucBlue,
and imaged using an inverted microscope (40x and 200x magnification). (B)
Cells were treated with 4 mM L-lactate for 4 h, co-stained with PI and NucBlue,
and imaged using an inverted microscope (40x and 200x magnification). (C) Llactate (4 mM) had a trend to increase PI stained cells compared to control,
although no statistical difference was found. (D) L-Lactate PI Flow Cytometry.
Cells treated with control DMEM for 4 h experienced 21.4% of the population
staining positive for PI. Cells treated with 4 mM L-lactate for 4 h experienced
31.6% of the population staining positive for PI. (E) PI Fluorescence
Quantification. The ratio and percentage of neurons that fluoresced positively for
PI staining when treated for 4 h with either control or 4 mM L-lactate.
NGF-derived PC12 cells treated with either DMEM as a control (Figure 28B) or increasing concentrations of L-lactate [1.5 mM (Figure 2-8C), 2 mM
(Figure 2-8D), 3 mM (Figure 2-8F), 4 mM (Figure 2-8G), 8 mM (Figure 2-8H)]
increased in percentage of cells staining positive for propidium iodide (PI) in a
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dose dependent manner (14.2, 18.5, 20.8, 27.2, 36.8, 53.4, respectively),
analyzed via flow cytometry.
A dose curve was plotted for the increasing concentrations of L-lactate,
and the EC50 was calculated to be 3.28 mM (Figure 2-8A). The experiment was
repeated at the L-lactate concentration of 4 mM and there was a significant (p >
0.05) increase in percentage of cells staining positive for PI compared to control
(Figure 2-8E).
PC12 cells were treated with either control DMEM (Figure 2-8I) or 4 mM Llactate in DMEM (Figure 2-8J, 2-8K), pre-loaded with PI and NucBlue ready
probes (ThermoFisher), and their fluorescence was quantified. Cells treated with
4 mM L-lactate significantly (p < 0.05) increased in percentage stained positive
for PI compared to control, however there was no significant difference in
percentage stained positive for NucBlue between the two groups.
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Figure 2-8. L-lactate Increases Cell Death in PC12 Cells.
(A) L-lactate induced a dose-dependent increase in cells staining positive for PI,
with an EC50 value of about 3.3 mM. Cells were treated with (B) control DMEM,
(C) 1.5 mM L-lactate, (D) 2 mM L-lactate, (F) 3 mM L-lactate, (G) 4 mM L-lactate,
or (H) 8 mM L-lactate for 4 hours before being stained with PI and analyzed via
flow cytometry. The percentage of cells stained positive for PI is the value to the
right of the red line. (E) 4 mM L-lactate significantly (p < 0.05) increased the
percentage of cells stained positive for PI compared to control. (I) Cells were
treated with DMEM as a control, co-stained with PI and NucBlue, and imaged
using an inverted microscope (40x magnification). (J) Cells were treated with 4
mM L-lactate for 4 h, co-stained with PI and NucBlue, and imaged using an
inverted microscope (40x magnification) and (K) 200x magnification.

2.5 Discussion
The present study evaluated the role L-lactate contributes towards toxicity
and neuronal degeneration in both primary neuronal cultures and dopaminergiclike NGF-derived PC12 cells. While a majority of literature on lactate/lactic acid
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from the 20th century concluded this substrate as being a dead-end metabolic
product present in exercising muscles, current research is growing towards more
important implications in CNS function and dysfunction. As such, we report
molecular mechanisms by which L-lactate can induce degenerative cascades in
primary neuronal cultures and dopaminergic-like PC12 cells.
The cytotoxic role of calcium ions to neurons has been well established in
the literature. Calcium build-up occurs intracellularly as a result of impaired
transporters, mitochondrial dysfunction, ER dysfunction, or a combination of
these factors. Increased levels of intracellular calcium can lead to excessive
neuronal depolarization, leading to “excitotoxicity” and subsequent cell death.
Due to the similarity in chemical structure between glutamate, the primary
excitatory neurotransmitter, and lactate, we hypothesized that elevated lactate
concentrations would elicit increases in intracellular calcium. To evaluate the
effects of L-lactate on intracellular calcium levels, we treated primary neuronal
cultures with 4 mM L-lactate for 4 h and stained the cells with Fluo-4AM, a
fluorescent cytosolic calcium dye. Real-time imaging quantification revealed that
L-lactate significantly increased the percentage of cells staining positive for Fluo4AM. It is likely that a combination of events contribute to the sustained increase
of calcium, such as activation of Ca2+-dependent receptors such as NMDA-R, or
Ca2+ leak from organelles such as the mitochondria during oxidative stress, or
the endoplasmic reticulum during ER-stress.
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Oxidative stress is a cellular condition that occurs when the generation of
reactive oxygen species (ROS) surpasses the ability of the body to neutralize
and effectively eliminate the ROS. It was not surprising for us to see increases in
cytosolic ROS following L-lactate (4 mM) treatment, as this has been established
in the literature from mitochondrial generated ATP. Mitochondrial dysfunction can
lead to reduced energy/ATP generation (11), impaired free radical scavenging
capabilities (52) and dysfunctional monocarboxylate transporters (29, 34, 70). It
is through these impaired cellular processes that ROS accumulates in cell bodies
such as neurons, eventually triggering an apoptotic-cascade ending in neuronal
death.
A crucial component of cellular homeostasis is intracellular pH levels, and
this is often disturbed in neurodegenerative models (AD, PD) as well as ischemia
(42). Modest decreases in pH have been shown to provide protective defenses
for cells, however severe acidosis (intracellular pH less than 6.4) increases
cellular damage observed in the pathologies listed above. It has been
demonstrated that oxidative stress can disrupt oxidative phosphorylation, leading
to increased production of lactate, with ensuing acidosis (42). As such, in this
study we were able to demonstrate that L-lactate, at elevated concentrations
commonly found in neurodegenerative disease models (4 mM), induces cytosolic
acidification, perhaps as a response to increased intracellular calcium, increased
ROS, or a combination.
Research has been conducted in primary culture mouse neurons and in
vivo showing that L-lactate can function as a signaling molecule that stimulates
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plasiticity-related gene expression in neurons (71). L-lactate functions as a
mediator for long-term plasticity and memory through the induction of expression
of immediate early genes (IEGs), such as early growth response 1 (EGR1) and
c-Fos. The expression of EGR1 is widely regulated by multiple environmental
factors and is implicated heavily in synaptic plasticity and information encoding
processes, suggesting a role for EGR1 in perceving the environment and forming
an appropriate response to stimuli. Furthermore, EGR1 has been associated in
the literature with neuropsychiatric illnesses where synaptic plasticity and activity
is dysregulated, such as stress-related mood disorders, schizophrenia, and
addiction models (21). Also, increased levels of EGR1 have been found in AD
brains,

with

implications

in

regulating

tau

phosphorylation

leading

to

acummulated proteins as is found in AD pathology (41). Interestingly, it has been
reported that while acute stressors elicit an increase in mRNA expression levels
of EGR1 and c-Fos in brain areas such as the neocortex, hippocampus, nucleus
accumbens, and the paraventricular nucleus (PVN) located in the hypothalamus,
chronic exposure to the same stressor produces a blunted IEG expression
response (18, 46, 55, 67). Consistent with current literature, in this study we
demonstrated that L-lactate (4 mM) induces increased mRNA expression of the
IEGs c-Fos and EGR1 at 1 h, with expression levels returning back towards
baseline at 4 h. This finding suggests a key role in L-lactate’s ability to impact
synaptic learning processes, which are often dysregulated in neurodegenerative
models.
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Protein structure and function is largely regulated by chaperone molecules
and lactic acidosis can contribute to conformational changes to tertiary protein
structure, leading to the misfolding of protein, thus reducing their activity and
further exacerbating the acidosis. This protein misfolding is largely implicated in
the pathological development of AD (6). A 2005 study reported increased protein
levels of GRP78, a molecular chaperone during the unfolded protein response
(UPR), in AD temporal cortex and hippocampus via Western blot (35). In
concurrence, in this study we demonstrated that L-lactate (4 mM) signficantly
increases mRNA expression levels of GRP78 at 4 h, suggesting a role of Llactate in eliciting the UPR. It has been shown in the literature that chronic UPR
can result in increased expression of CHOP (DDIT3), a pro-apoptotic
transcription factor implicated in the ER stress response. In the current study we
showed that L-lactate (4 mM) induced a signficant decrease in mRNA expression
levels of CHOP at 4h but not 1h, suggesting that the neurons were experiencing
uncontrollable protein misfolding and subsequent death.
A hallmark of neuronal homeostasis and regulation lies through vesicular
transport. Vesicular monoamine transporter 2 (VMAT2) is expressed primarily in
the CNS, with roles in organizing and releasing neurotransmitters. Dysregulation
of VMAT2 through exogenous stimulant exposure has been implicated in
neurotoxicity and addiction (24). Dyfunction of VMAT2 has also been implicated
in PD pathologies (40). Furthermore, a 2005 study showed VMAT2 knock-out
mice were unable to store/release dopamine in their synapses, indicating the
importance of VMAT2 in proper neurotransmission (17). Consistent with current
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literature, in this study we demonstrated that VMAT2 mRNA expression is
increased at 1 h, with levels returning back towards baseline at 4 h. This
suggests that acute exposure to a stimulant such as L-lactate can induce
increased vesicular transport in neuronal synapses through acidification and/or
calcium levels, however chronic exposure can diminish the ability of VMAT2 to
successfully release and take-up neurotransmitters in the synapse, leading to
further cellular dysregulation.
Using flow cytometry, we confirmed that NGF-derived PC12 cells
incubated with L-lactate for 4 h increased positive PI staining in a dose
dependent manner (Figure 1). A dose-response curve revealed an EC50 value for
L-lactate of 3.28 mM (Figure 1A). Blood lactate concentrations are usually 1-2
mM at rest, however with excess accumulation as experienced during intense
exercise, these levels can exceed 20 mM (12). Rises in CSF lactate have been
well established in neurodegenerative disease models (2, 3, 44, 49, 62, 71, 72).
It is also reported that blood or CSF lactate increases (>2.1 mM) (32) can be an
indicator of mitochondrial disease. Our EC50 value for L-lactate-induced
increases in cell death (represented by increased percentage of cells staining
positive for PI) corresponds with the apparent increases in brain L-lactate
concentrations in neurodegenerative models reported thoroughly in the literature.
In support of the quantitative cell death observed via flow cytometry, we also
observed significant increases in fluoresced PC12 cells following L-lactate (4
mM) treatment via real-time imaging versus control. The flow cytometry and realtime imaging experiments were re-conducted using primary neuronal cultures
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with similar trends observed, further supporting the role of lactate in modulating
CNS activity. There is a growing basis of research indicating that accumulation of
lactate in the central nervous system, through impairment of MCTs (29, 34, 70),
altered activity of lactate dehydrogenase (LDH), and/or hypoxic/ischemic
conditions (63), can lead to metabolic acidosis, increased ROS, and increased
levels of intracellular calcium; all precursors to cell death individually and in
combination. This current study provides further evidence for the role of lactate in
neurodegeneration in the CNS, and allows for continued studies into precise
cellular mechanistic pathways.
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Summary, Limitations, and Future Directions
3.1 Summary
Dysregulation of homeostatic mechanisms in the CNS remain a
cornerstone of neurodegenerative diseases, ischemia reperfusion injuries, and
physiological aging. While neurodegenerative disorder studies focus largely on
the clinical presentation of these diseases such as protein aggregation, little
research has been done to explore the effects of potential biochemical markers
that facilitate the homeostatic dysregulation. As such, we explored the effects of
lactate on neuronal function.
In the current study we explored whether lactate could induce cytotoxic
mechanisms that are heavily implicated in neuronal degeneration. We
demonstrated that L-lactate activates a cellular cascade that results in increased
cytosolic calcium, increased cytosolic ROS and increased intracellular pH.
Furthermore, lactate induced increases in mRNA expression levels of EGR1 and
c-Fos, proteins that are upregulated during synaptic plasticity processes. Lactate
also induced increases in mRNA expression levels of GRP78 and CHOP,
proteins upregulated during ER stress and UPR. In support of the cytotoxic
mechanisms explored above, L-lactate also induced significant increases in cell
death experienced in both primary neuronal cultures and dopaminergic-like PC12
cells. Taken together, this suggests that lactate-induced cell death is a result or
contribution of several cellular pathways explored in this study, and can provide
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further insight to the development and maintenance of neurodegenerative
diseases.

3.2 Limitations
It is important to note several limitations of the present study. First, all
experiments were conducted on primary neuronal cultures, not isolated from
specific areas of the brain. This could have implications for the data sets, as
various brain areas are correlated with various levels of expression of substrates
and receptors. In addition, the flow cytometry machine that was used to carry out
the PI flow cytometry data collection does not contain a UV laser line, a
necessary component for the use of the NucBlue stain. NucBlue permeates all
cell membranes (intact and compromised), which can provide a clearer
understanding of the effects of L-lactate on the whole neuronal population. To
improvise this equipment shortcoming, we used PI stain alone, which stains
compromised membranes but cannot permeate and stain cells with an intact
membrane, still allowing us to quantify the cell death experienced upon L-lactate
treatment.
Our current study with lactate only utilized cell culture. As is common in
research practice, studies progress from cell culture, to animal models and
eventually make it to human trials. A limitation for this study is that we lack
animal model support. As such, future studies will include animal models and the
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contributions of lactic acid/lactate to the development of neurodegenerative
disease.

3.3 Future Directions
Since we have identified lactate to contribute to increases in intracellular
calcium concentrations, we would like to continue our research into more precise
signaling pathways. Specifically, we plan on exploring the effects of lactate on
NMDA-R pathways, as it has been demonstrated in the literature that oligomeric
forms of β-amyloid, as well as lactate, have been shown to interact with NMDAR, leading to increases in levels of intracellular calcium, mitochondrial calcium
excess, oxidative stress, and apoptosis (19).
We would also like to expand our research to routes further exploring the
role of lactate in the UPR and subsequent protein aggregation that is common
among neurodegenerative disorders such as AD, PD, and dementia with lewy
bodies.
It would be beneficial for the study to include acute versus chronic exposure
to lactate, as it is pertinent to further understanding lactate’s role in
neurodegenerative diseases, which progress chronically over time. This could be
achieved through acute administration of lactate through tail vein infusion, and
the chronic intracerebrovascular (ICV) infusion of lactate over four weeks to look
for neurodegenerative markers for degeneration.
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A

Raw Data and Statistics

Table A-1. Two-tailed T-test for mRNA Expression of GRP78 (HSPA5)
Table Analyzed

HSPA5 Neurons 3_13_18

Column A

control

vs

vs

Column C

4 mm Lactate 4 hr

Unpaired t test
P value

0.0145

P value summary

*

Are means signif. different? (P < 0.05)

Yes

One- or two-tailed P value?

Two-tailed

t, df

t=3.398 df=6

How big is the difference?
Mean ± SEM of column A

1.006 ± 0.06478 N=4

Mean ± SEM of column C

1.395 ± 0.09447 N=4

Difference between means

-0.3893 ± 0.1146

95% confidence interval

-0.6696 to -0.1090

R square

0.6581

F test to compare variances
F,DFn, Dfd

2.127, 3, 3

P value

0.5513
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P value summary

ns

Are variances significantly different?

No

Table A-2. Two-tailed T-test for mRNA Expression of EGR1
Table Analyzed

EGR1 Neurons 3_13_18

Column A

control

vs

vs

Column B

4 mM Lactate 1 hr

Unpaired t test
P value

0.0007

P value summary

***

Are means signif. different? (P < 0.05)

Yes

One- or two-tailed P value?

Two-tailed

t, df

t=6.410 df=6

How big is the difference?
Mean ± SEM of column A

1.006 ± 0.06478 N=4

Mean ± SEM of column B

2.157 ± 0.1675 N=4

Difference between means

-1.151 ± 0.1796

95% confidence interval

-1.591 to -0.7118

R square

0.8726

F test to compare variances
F,DFn, Dfd

6.684, 3, 3
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P value

0.1530

P value summary

ns

Are variances significantly different?

No

Table A-3. Two-tailed T-test for mRNA Expression of c-FOS (Control vs 1 h)
Table Analyzed

c-fos Neurons 3_13_18

Column A

control

vs

vs

Column B

4 mM Lactate 1 hr

.
Unpaired t test
P value

< 0.0001

P value summary

****

Are means signif. different? (P < 0.05)

Yes

One- or two-tailed P value?

Two-tailed

t, df

t=12.52 df=6

How big is the difference?
Mean ± SEM of column A

1.006 ± 0.06478 N=4

Mean ± SEM of column B

5.773 ± 0.3751 N=4

Difference between means

-4.767 ± 0.3807

95% confidence interval

-5.699 to -3.836

R square

0.9632

F test to compare variances
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F,DFn, Dfd

33.53, 3, 3

P value

0.0166

P value summary

*

Are variances significantly different?

Yes

Table A-4. Two-tailed T-test for mRNA Expression of c-FOS (Control vs 4 h)
Table Analyzed

c-fos Neurons 3_13_18

Column A

control

vs

vs

Column C

4 mm Lactate 4 hr

Unpaired t test
P value

< 0.0001

P value summary

****

Are means signif. different? (P < 0.05)

Yes

One- or two-tailed P value?

Two-tailed

t, df

t=12.52 df=6

How big is the difference?
Mean ± SEM of column A

1.006 ± 0.06478 N=4

Mean ± SEM of column C

0.1003 ± 0.03217 N=4

Difference between means

0.9058 ± 0.07233

95% confidence interval

0.7288 to 1.083

R square

0.9631
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F test to compare variances
F,DFn, Dfd

4.054, 3, 3

P value

0.2804

P value summary

ns

Are variances significantly different?

No

Table A-5. Two-tailed T-test for mRNA Expression of c-FOS (1 h vs 4 h)
Table Analyzed

c-fos Neurons 3_13_18

Column B

4 mM Lactate 1 hr

vs

vs

Column C

4 mm Lactate 4 hr

Unpaired t test
P value

< 0.0001

P value summary

****

Are means signif. different? (P < 0.05)

Yes

One- or two-tailed P value?

Two-tailed

t, df

t=15.07 df=6

How big is the difference?
Mean ± SEM of column B

5.773 ± 0.3751 N=4

Mean ± SEM of column C

0.1003 ± 0.03217 N=4

Difference between means

5.673 ± 0.3765

95% confidence interval

4.752 to 6.594
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R square

0.9743

F test to compare variances
F,DFn, Dfd

135.9, 3, 3

P value

0.0021

P value summary

**

Are variances significantly different?

Yes

Table A-6. Two-tailed T-test for mRNA Expression of CHOP (DDIT3) (Control vs
1 h)
Table Analyzed

Ddit3 Neurons 3_13_18

Column A

control

vs

vs

Column B

4 mM Lactate 1 hr

Unpaired t test
P value

0.6199

P value summary

ns

Are means signif. different? (P < 0.05)

No

One- or two-tailed P value?

Two-tailed

t, df

t=0.5228 df=6

How big is the difference?
Mean ± SEM of column A

1.006 ± 0.06478 N=4

Mean ± SEM of column B

0.9180 ± 0.1555 N=4
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Difference between means

0.08806 ± 0.1684

95% confidence interval

-0.3241 to 0.5002

R square

0.04357

F test to compare variances
F,DFn, Dfd

5.760, 3, 3

P value

0.1844

P value summary

ns

Are variances significantly different?

No

Table A-7. Two-tailed T-test for mRNA Expression of CHOP (DDIT3) (Control vs
4 h)
Table Analyzed

Ddit3 Neurons 3_13_18

Column A

control

vs

vs

Column C

4 mm Lactate 4 hr

Unpaired t test
P value

< 0.0001

P value summary

****

Are means signif. different? (P < 0.05)

Yes

One- or two-tailed P value?

Two-tailed

t, df

t=14.63 df=6

How big is the difference?
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Mean ± SEM of column A

1.006 ± 0.06478 N=4

Mean ± SEM of column C

0.05552 ± 0.004758 N=4

Difference between means

0.9506 ± 0.06496

95% confidence interval

0.7916 to 1.110

R square

0.9727

F test to compare variances
F,DFn, Dfd

185.4, 3, 3

P value

0.0013

P value summary

**

Are variances significantly different?

Yes
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Table A-8. Two-tailed T-test for mRNA Expression of VMAT2 (Control vs 1 h)
Table Analyzed

vmat2 Neurons 3_13_18

Column A

control

vs

vs

Column B

4 mM Lactate 1 hr

Unpaired t test
P value

0.0003

P value summary

***

Are means signif. different? (P < 0.05)

Yes

One- or two-tailed P value?

Two-tailed

t, df

t=7.251 df=6

How big is the difference?
Mean ± SEM of column A

1.006 ± 0.06478 N=4

Mean ± SEM of column B

2.057 ± 0.1297 N=4

Difference between means

-1.051 ± 0.1450

95% confidence interval

-1.406 to -0.6963

R square

0.8976

F test to compare variances
F,DFn, Dfd

4.007, 3, 3

P value

0.2842

P value summary

ns

Are variances significantly different?

No
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Table A-9. Two-tailed T-test for mRNA Expression of VMAT2 (Control vs 4 h)
Table Analyzed

vmat2 Neurons 3_13_18

Column A

control

vs

vs

Column C

4 mm Lactate 4 hr

Unpaired t test
P value

0.0661

P value summary

ns

Are means signif. different? (P < 0.05)

No

One- or two-tailed P value?

Two-tailed

t, df

t=2.243 df=6

How big is the difference?
Mean ± SEM of column A

1.006 ± 0.06478 N=4

Mean ± SEM of column C

1.301 ± 0.1142 N=4

Difference between means

-0.2945 ± 0.1313

95% confidence interval

-0.6158 to 0.02684

R square

0.4560

F test to compare variances
F,DFn, Dfd

3.109, 3, 3

P value

0.3765

P value summary

ns
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Are variances significantly different?

No

Table A-10. Two-tailed T-test for PI Quantification in Neurons
Table Analyzed

PI Lactate 4 hr neurons 2_15_18

Column A

0

vs

vs

Column B

4

Unpaired t test
P value

0.0021

P value summary

**

Are means signif. different? (P < 0.05)

Yes

One- or two-tailed P value?

Two-tailed

t, df

t=4.255 df=9

How big is the difference?
Mean ± SEM of column A

18.86 ± 1.535 N=5

Mean ± SEM of column B

31.83 ± 2.456 N=6

Difference between means

-12.97 ± 3.049

95% confidence interval

-19.87 to -6.077

R square

0.6680

F test to compare variances
F,DFn, Dfd

3.074, 5, 4

P value

0.2992
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P value summary

ns

Are variances significantly different?

No

Table A-11. Two-tailed T-test for RT-ROS Quantification in Neurons
Table Analyzed

ROS lactate

Column A

0

vs

vs

Column B

4

Unpaired t test
P value

0.0214

P value summary

*

Are means signif. different? (P < 0.05)

Yes

One- or two-tailed P value?

Two-tailed

t, df

t=2.725 df=10

How big is the difference?
Mean ± SEM of column A

1.755 ± 0.4230 N=6

Mean ± SEM of column B

4.115 ± 0.7557 N=6

Difference between means

-2.360 ± 0.8660

95% confidence interval

-4.289 to -0.4302

R square

0.4261

F test to compare variances
F,DFn, Dfd

3.192, 5, 5
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P value

0.2285

P value summary

ns

Are variances significantly different?

No

Table A-12. Two-tailed T-test for RT-pH Quantification in Neurons
Table Analyzed

pHi lactate

Column A

0

vs

vs

Column B

4

Unpaired t test
P value

0.0088

P value summary

**

Are means signif. different? (P < 0.05)

Yes

One- or two-tailed P value?

Two-tailed

t, df

t=3.246 df=10

How big is the difference?
Mean ± SEM of column A

0.3227 ± 0.04263 N=6

Mean ± SEM of column B

0.5975 ± 0.07315 N=6

Difference between means

-0.2748 ± 0.08466

95% confidence interval

-0.4634 to -0.08614

R square

0.5130

F test to compare variances
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F,DFn, Dfd

2.944, 5, 5

P value

0.2610

P value summary

ns

Are variances significantly different?

No

Table A-13. Two-tailed T-test for RT-Calcium Quantification in Neurons
Table Analyzed

Calcium Lactate

Column A

0

vs

vs

Column B

4

Unpaired t test
P value

0.0116

P value summary

*

Are means signif. different? (P < 0.05)

Yes

One- or two-tailed P value?

Two-tailed

t, df

t=3.156 df=9

How big is the difference?
Mean ± SEM of column A

0.05953 ± 0.004102 N=5

Mean ± SEM of column B

0.2159 ± 0.04470 N=6

Difference between means

-0.1564 ± 0.04956

95% confidence interval

-0.2685 to -0.04428

R square

0.5252
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F test to compare variances
F,DFn, Dfd

142.5, 5, 4

P value

0.0003

P value summary

***

Are variances significantly different?

Yes

Table A-14. Two-tailed T-test for RT-PI Quantification in Neurons
Table Analyzed

PI Lactate Column

Column A

0

vs

vs

Column B

4

Unpaired t test
P value

0.0116

P value summary

*

Are means signif. different? (P < 0.05)

Yes

One- or two-tailed P value?

Two-tailed

t, df

t=3.585 df=6

How big is the difference?
Mean ± SEM of column A

14.95 ± 0.5188 N=4

Mean ± SEM of column B

31.58 ± 4.608 N=4

Difference between means

-16.63 ± 4.637

95% confidence interval

-27.97 to -5.277

R square

0.6817
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F test to compare variances
F,DFn, Dfd

78.89, 3, 3

P value

0.0047

P value summary

**

Are variances significantly different?

Yes

Table A-15. Two-tailed T-test for RT-pH Quantification in PC12 Cells
Table Analyzed

pHi

Column A

Control

vs

vs

Column B

4 mM L-Lac

Unpaired t test
P value

0.0080

P value summary

**

Are means signif. different? (P < 0.05)

Yes

One- or two-tailed P value?

Two-tailed

t, df

t=3.303 df=10

How big is the difference?
Mean ± SEM of column A

1.210 ± 0.3064 N=6

Mean ± SEM of column B

2.341 ± 0.1530 N=6

Difference between means

-1.131 ± 0.3424

95% confidence interval

-1.894 to -0.3680
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R square

0.5217

F test to compare variances
F,DFn, Dfd

4.012, 5, 5

P value

0.1536

P value summary

ns

Are variances significantly different?

No

Table A-16. Two-tailed T-test for RT-ROS Quantification in PC12 Cells
Table Analyzed

Cyto ROS

Column A

Control

vs

vs

Column B

4 mM L-Lac

Unpaired t test
P value

0.0246

P value summary

*

Are means signif. different? (P < 0.05)

Yes

One- or two-tailed P value?

Two-tailed

t, df

t=2.644 df=10

How big is the difference?
Mean ± SEM of column A

3.285 ± 0.7930 N=6

Mean ± SEM of column B

5.786 ± 0.5157 N=6

Difference between means

-2.501 ± 0.9459
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95% confidence interval

-4.609 to -0.3935

R square

0.4114

F test to compare variances
F,DFn, Dfd

2.364, 5, 5

P value

0.3668

P value summary

ns

Are variances significantly different?

No

Table A-17. Non-linear fit for dose-dependent response of PC12 cells to L-lactate
Boltzmann sigmoidal
Best-fit values
Bottom

12.33

Top

43.83

V50

3.282

Slope

1.285

Std. Error
Bottom

7.845

Top

4.669

V50

0.7646

Slope

0.9474

95% Confidence Intervals
Bottom

-4.088 to 28.75

Top

34.06 to 53.61

V50

1.682 to 4.883
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Slope

-0.6979 to 3.268

Goodness of Fit
Degrees of Freedom

19

R square

0.6958

Absolute Sum of Squares

923.9

Sy.x

6.973

Number of points
Analyzed

23
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